Azelis Group NV (EBR:AZE)

Market Cap	3.22B
Revenue (ttm)	4.23B
Net Income (ttm)	169.42M
Shares Out	243.45M
EPS (ttm)	0.69
PE Ratio	19.14
Forward PE	14.42
Dividend	0.23 (1.68%)
Ex-Dividend Date	Jun 27, 2025

Volume	447,734
Average Volume	272,531
Open	13.80
Previous Close	13.68
Day's Range	13.21 - 13.99
52-Week Range	12.82 - 21.00
Beta	0.58
RSI	38.97
Earnings Date	Jul 31, 2025

About Theseus Pharmaceuticals

Azelis Group NV engages in the distribution and sale of specialty chemicals and food ingredients. The company sells specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, flavours and fragrances, and agricultural environmental solutions; and industrial chemicals industry, such as CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper ma...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1996
• Employees: 4,321
• Stock Exchange: Euronext Brussels
• Ticker Symbol: AZE

Financial Performance

In 2024, Azelis Group NV's revenue was 4.21 billion, an increase of 1.49% compared to the previous year's 4.15 billion. Earnings were 180.69 million, an increase of 1.68%.